Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
Angiotensin II (Ang-II) plays a key role as a vasoconstrictor in controlling blood pressure and electrolyte/fluid homeostasis. Recently it has also been shown that this peptide is a cytokine, acting as a growth factor in cardiovascular and stromal cells. In addition, the physiological function of An...
Main Authors: | Hiroji Uemura, Hitoshi Ishiguro, Yoshinobu Kubota |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-12-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://oncologyreviews.org/index.php/or/article/view/135 |
Similar Items
-
Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01) -
Angiotensin II receptor blockers as a risk factor for skin ulcers
by: Raúl Gonzalez-Fregoso, et al.
Published: (2021-10-01) -
ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01) -
Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01) -
Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor
by: Lulu SUN, et al.
Published: (2016-09-01)